US3926891A
(en)
|
1974-03-13 |
1975-12-16 |
Dow Chemical Co |
Method for making a crosslinkable aqueous solution which is useful to form soft, water-swellable polyacrylate articles
|
US3997484A
(en)
|
1974-04-03 |
1976-12-14 |
The United States Of America As Represented By The Secretary Of Agriculture |
Highly-absorbent starch-containing polymeric compositions
|
US3935099A
(en)
|
1974-04-03 |
1976-01-27 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of reducing water content of emulsions, suspensions, and dispersions with highly absorbent starch-containing polymeric compositions
|
US4090013A
(en)
|
1975-03-07 |
1978-05-16 |
National Starch And Chemical Corp. |
Absorbent composition of matter
|
JPS51125468A
(en)
|
1975-03-27 |
1976-11-01 |
Sanyo Chem Ind Ltd |
Method of preparing resins of high water absorbency
|
JPS5346389A
(en)
|
1976-10-07 |
1978-04-25 |
Kao Corp |
Preparation of self-crosslinking polymer of acrylic alkali metal salt
|
US4190562A
(en)
|
1977-04-04 |
1980-02-26 |
The B. F. Goodrich Company |
Improved water absorbent copolymers of copolymerizable carboxylic acids and acrylic or methacrylic esters
|
US4470975A
(en)
|
1977-10-21 |
1984-09-11 |
The Johns Hopkins University |
Method and composition for the elimination of water from an animal body
|
US4286082A
(en)
|
1979-04-06 |
1981-08-25 |
Nippon Shokubai Kagaku Kogyo & Co., Ltd. |
Absorbent resin composition and process for producing same
|
JPS6025045B2
(ja)
|
1980-03-19 |
1985-06-15 |
製鉄化学工業株式会社 |
塩水吸収能のすぐれたアクリル酸重合体の製造方法
|
JPS57158209A
(en)
|
1981-03-25 |
1982-09-30 |
Kao Corp |
Production of bead-form highly water-absorbing polymer
|
JPS5832607A
(ja)
|
1981-08-20 |
1983-02-25 |
Kao Corp |
吸水性に優れた吸水材料の製造法
|
US4985518A
(en)
|
1981-10-26 |
1991-01-15 |
American Colloid Company |
Process for preparing water-absorbing resins
|
JPS6187702A
(ja)
|
1984-10-05 |
1986-05-06 |
Seitetsu Kagaku Co Ltd |
吸水性樹脂の製造方法
|
US4708997A
(en)
|
1985-07-22 |
1987-11-24 |
The Dow Chemical Company |
Suspending agent for the suspension polymerization of water-soluble monomers
|
US4806532A
(en)
|
1985-10-08 |
1989-02-21 |
Mayo Foundation For Medical Education And Research |
Inhibition of epithelial phosphate transport
|
DE3544770A1
(de)
|
1985-12-18 |
1987-06-19 |
Stockhausen Chem Fab Gmbh |
Verfahren und vorrichtung zum kontinuierlichen herstellen von polymerisaten und copolymerisaten der acrylsaeure und/oder methacrylsaeure
|
US4766004A
(en)
|
1986-12-19 |
1988-08-23 |
Warner-Lambert Company |
Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition
|
IT1217123B
(it)
|
1987-02-05 |
1990-03-14 |
Rotta Research Lab |
Derivati otticamente attivi dell acido 5 pentilammino 5 oxo pentanoico r ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
|
US4999200A
(en)
|
1987-12-09 |
1991-03-12 |
Marion Laboratories |
Psyllium tablet composition, method of manufacture and method of use
|
US5149541A
(en)
|
1988-10-03 |
1992-09-22 |
The Procter & Gamble Company |
Psyllium-containing produces with a distribution of particle size
|
US5145906A
(en)
|
1989-09-28 |
1992-09-08 |
Hoechst Celanese Corporation |
Super-absorbent polymer having improved absorbency properties
|
US5126150A
(en)
|
1990-10-01 |
1992-06-30 |
The Procter & Gamble Company |
Compositions containing psyllium
|
HUT64023A
(en)
|
1991-03-22 |
1993-11-29 |
Sandoz Ag |
Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
|
FR2674849B1
(fr)
|
1991-04-02 |
1994-12-23 |
Logeais Labor Jacques |
Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
|
US5140102A
(en)
|
1991-09-23 |
1992-08-18 |
Monsanto Company |
Pentadecapeptide, guanylin, which stimulates intestinal guanylate cyclase
|
CA2151741C
(fr)
|
1991-12-30 |
2001-12-11 |
Alan Justice |
Methode analgesique et amelioration d'une methode analgesique utilisant un opiace
|
US5824645A
(en)
|
1991-12-30 |
1998-10-20 |
Neurex Corporation |
Method of treating inflammation
|
US5969097A
(en)
|
1992-06-23 |
1999-10-19 |
G. D. Searle & Co. |
Human guanylin
|
EP0612723B1
(fr)
|
1993-02-20 |
1997-08-27 |
Hoechst Aktiengesellschaft |
Benzoylguanidines substituées, procédé de leur préparation, leur utilisation comme médicament, comme inhibiteurs de l'échange cellulaire de Na+/H+ ou comme agent diagnostique et médicament les contenant
|
US5629377A
(en)
|
1993-03-10 |
1997-05-13 |
The Dow Chemical Company |
Water absorbent resin particles of crosslinked carboxyl containing polymers and method of preparation
|
IL109570A0
(en)
|
1993-05-17 |
1994-08-26 |
Fujisawa Pharmaceutical Co |
Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
|
US5489670A
(en)
|
1993-10-29 |
1996-02-06 |
G. D. Searle & Co. |
Human uroguanylin
|
US5610145A
(en)
|
1994-04-15 |
1997-03-11 |
Warner-Lambert Company |
Tachykinin antagonists
|
US5650222A
(en)
|
1995-01-10 |
1997-07-22 |
The Procter & Gamble Company |
Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios
|
DE19518796A1
(de)
|
1995-05-22 |
1996-11-28 |
Hoechst Ag |
Fluorphenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US6054429A
(en)
|
1996-03-08 |
2000-04-25 |
Elan Pharmaceuticals, Inc. |
Epidural method of producing analgesia
|
US5795864A
(en)
|
1995-06-27 |
1998-08-18 |
Neurex Corporation |
Stable omega conopetide formulations
|
PT835126E
(pt)
|
1995-06-27 |
2003-07-31 |
Elan Pharm Inc |
Composicoes e formulacoes para a producao de analgesia e para a inibicao de patologias dolorosas neuropaticas
|
US5550167A
(en)
|
1995-08-30 |
1996-08-27 |
The Procter & Gamble Company |
Absorbent foams made from high internal phase emulsions useful for acquiring aqueous fluids
|
US6277862B1
(en)
|
1995-11-24 |
2001-08-21 |
Smithkline Beecham S.P.A. |
Quinoline derivatives
|
GB9524104D0
(en)
|
1995-11-24 |
1996-01-24 |
Smithkline Beecham Spa |
Novel compounds
|
DE19548812A1
(de)
|
1995-12-27 |
1997-07-03 |
Hoechst Ag |
Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
|
EP0837055A1
(fr)
|
1996-07-30 |
1998-04-22 |
Hoechst Aktiengesellschaft |
Indanylidineacétylguanidines substituées comme inhibiteur de l'échangeur Na+/H+, leur procédé de préparation, leur utilisation comme médicament ou agent diagnostique ainsi que médicament les contenant
|
DE19633966A1
(de)
|
1996-08-22 |
1998-02-26 |
Hoechst Ag |
Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
AU4176997A
(en)
|
1996-09-16 |
1998-04-02 |
Warner-Lambert Company |
3-alkyl-3-phenyl-piperidines
|
ES2302350T3
(es)
|
1997-02-28 |
2008-07-01 |
Nycomed Gmbh |
Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa.
|
NZ329807A
(en)
|
1997-04-23 |
2000-07-28 |
Pfizer |
NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
|
KR100219918B1
(ko)
|
1997-07-03 |
1999-09-01 |
김윤 |
대장선택적 약물전달용 조성물
|
US20010006972A1
(en)
|
1998-04-21 |
2001-07-05 |
Stephen A. Williams |
Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
|
KR20000011247A
(ko)
|
1998-07-23 |
2000-02-25 |
김윤 |
다당류를이용한대장선택성약물전달조성물및약학제제
|
DE19849722A1
(de)
|
1998-10-28 |
2000-05-04 |
Aventis Pharma Gmbh |
Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
WO2000043402A2
(fr)
|
1999-01-21 |
2000-07-27 |
Board Of Regents, The University Of Texas System |
Inhibiteurs de cotransport de na/phosphate de membrane apicale intestinale
|
FR2789493B1
(fr)
|
1999-02-09 |
2001-03-09 |
Gemplus Card Int |
Procede de detection d'objets portables et systeme de mise en oeuvre
|
US6624150B2
(en)
|
1999-02-26 |
2003-09-23 |
Inspire Pharmaceuticals, Inc. |
Method of treating gastrointestinal tract disease with purinergic receptor agonists
|
US6287609B1
(en)
|
1999-06-09 |
2001-09-11 |
Wisconsin Alumni Research Foundation |
Unfermented gel fraction from psyllium seed husks
|
JP2004513870A
(ja)
|
1999-07-19 |
2004-05-13 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
ナトリウムチャネルブロッカーの結合物及びその使用法
|
AR030911A1
(es)
|
1999-07-20 |
2003-09-03 |
Smithkline Beecham Corp |
Uso de n-aril-2-sulfonamidobenzamidas para la manufactura de un medicamento para el tratamiento de la insuficiencia renal cronica y composiciones farmaceuticas
|
US6107356A
(en)
|
1999-08-23 |
2000-08-22 |
The Procter & Gamble Company |
High suction polymeric foam materials
|
DE19941764A1
(de)
|
1999-09-02 |
2001-03-15 |
Aventis Pharma Gmbh |
Substituierte Acylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente oder Diagnostika sowie sie enthaltende Medikamente
|
SE9903291D0
(sv)
|
1999-09-15 |
1999-09-15 |
Astra Ab |
New process
|
DE19945302A1
(de)
|
1999-09-22 |
2001-03-29 |
Merck Patent Gmbh |
Biphenylderivate als NHE-3-Inhibitoren
|
RU2001114518A
(ru)
*
|
1999-09-29 |
2003-04-20 |
Орто-Макнейл Фармасьютикал, Инк. (Us) |
Изонипекотамиды для лечения опосредованных интегринами нарушений
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
DE60013630T2
(de)
|
1999-11-01 |
2005-09-15 |
John Cardiff Rhodes |
Arzneimittel zur behandlung von darmverstopfung und reizkolon
|
AUPQ514600A0
(en)
|
2000-01-18 |
2000-02-10 |
James Cook University |
Brain injury treatment
|
AU3580001A
(en)
|
2000-03-01 |
2001-09-12 |
University College London |
Modulators of the endocannabinoid uptake and of the vallinoid receptors
|
DE10015248A1
(de)
|
2000-03-28 |
2001-10-04 |
Merck Patent Gmbh |
Bisamidino-Verbindungen als NHE-3 Inhibitoren
|
DE10019062A1
(de)
|
2000-04-18 |
2001-10-25 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren
|
JP2003531856A
(ja)
|
2000-05-02 |
2003-10-28 |
スミスクライン・ビーチャム・コーポレイション |
リン酸輸送阻害剤
|
PL359931A1
(en)
|
2000-05-12 |
2004-09-06 |
Smithkline Beecham Corporation |
Phosphate transport inhibitors
|
DE10043667A1
(de)
|
2000-09-05 |
2002-03-14 |
Merck Patent Gmbh |
2-Guanidino-4-aryl-chinazoline
|
US6414016B1
(en)
|
2000-09-05 |
2002-07-02 |
Sucampo, A.G. |
Anti-constipation composition
|
DE10046993A1
(de)
|
2000-09-22 |
2002-04-11 |
Aventis Pharma Gmbh |
Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament
|
WO2002028353A2
(fr)
|
2000-10-05 |
2002-04-11 |
Smithkline Beecham Corporation |
Inhibiteur du transport de phosphate
|
WO2002040039A2
(fr)
|
2000-11-20 |
2002-05-23 |
Dow Global Technologies Inc. |
Utilisation in vivo de polymeres absorbeurs d'eau
|
DE10063294A1
(de)
|
2000-12-19 |
2002-07-04 |
Aventis Pharma Gmbh |
Substituierte Heterocyclo-Norbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
EP2944648B1
(fr)
|
2001-03-29 |
2019-11-13 |
Bausch Health Ireland Limited |
Agonistes du récepteur du type Guanylate Cyclase servant au traitement de l'inflammation d'organe
|
US6736705B2
(en)
|
2001-04-27 |
2004-05-18 |
Hitachi Global Storage Technologies |
Polishing process for glass or ceramic disks used in disk drive data storage devices
|
US20030216449A1
(en)
|
2001-05-11 |
2003-11-20 |
Joseph Weinstock |
Phosphate transport inhibitors
|
MY134211A
(en)
|
2001-05-18 |
2007-11-30 |
Smithkline Beecham Corp |
Novel use
|
JP2007131532A
(ja)
|
2001-09-28 |
2007-05-31 |
Kirin Brewery Co Ltd |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
FR2830451B1
(fr)
|
2001-10-09 |
2004-04-30 |
Inst Nat Sante Rech Med |
Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
|
US6911453B2
(en)
|
2001-12-05 |
2005-06-28 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
|
AU2002354410A1
(en)
|
2001-12-05 |
2003-06-17 |
Japan Tobacco Inc. |
Triazole compound and medicinal use thereof
|
HUP0600854A2
(en)
|
2001-12-05 |
2007-02-28 |
Sanofi Aventis Deutschland |
Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
|
DE10161767A1
(de)
|
2001-12-15 |
2003-06-26 |
Merck Patent Gmbh |
2-Guanidino-4-heterocyclyl-chinazoline
|
EP1321142A1
(fr)
|
2001-12-21 |
2003-06-25 |
Novartis AG |
Forme solide pour l'administration orale du Tégaserode
|
US6703405B2
(en)
|
2001-12-22 |
2004-03-09 |
Aventis Pharma Deutschland Gmbh |
Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as a medicament, and medicament containing them
|
DE10163992A1
(de)
|
2001-12-24 |
2003-07-03 |
Merck Patent Gmbh |
4-Aryl-chinazoline
|
US7119120B2
(en)
|
2001-12-26 |
2006-10-10 |
Genzyme Corporation |
Phosphate transport inhibitors
|
WO2003077897A1
(fr)
|
2002-03-15 |
2003-09-25 |
Cypress Bioscience, Inc. |
Inhibiteurs de recaptage de 5-ht pour le traitement de syndromes de la douleur viscerale
|
WO2003080630A2
(fr)
|
2002-03-19 |
2003-10-02 |
Genzyme Corporation |
Inhibiteurs de transport du phosphate
|
PL371596A1
(en)
|
2002-05-17 |
2005-06-27 |
Merck Patent Gmbh |
Use of compounds that are effective as selective opiate receptor modulators
|
US7014862B2
(en)
|
2002-05-20 |
2006-03-21 |
The Procter & Gamble Company |
Chewable compositions containing a gel-forming extract of psyllium
|
US6923466B2
(en)
|
2002-12-17 |
2005-08-02 |
James Tsai |
Collapsible handcart capable of extending the area of carrier by operating handle
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US20050054705A1
(en)
|
2003-02-04 |
2005-03-10 |
Aventis Pharma Deutschland Gmbh |
N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
|
US7026303B2
(en)
|
2003-02-18 |
2006-04-11 |
The Procter & Gamble Company |
Compositions comprising a polysaccharide component and one or more coating layers
|
WO2004085448A2
(fr)
|
2003-03-19 |
2004-10-07 |
Genzyme Corporation |
Inhibiteurs du transport de phosphate comprenant un groupe phosphinyl-phosphonate insature
|
US7241775B2
(en)
|
2003-03-24 |
2007-07-10 |
Sanofi-Aventis Deutschland Gmbh |
Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines
|
DE10312963A1
(de)
|
2003-03-24 |
2004-10-07 |
Aventis Pharma Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
US8134015B2
(en)
|
2003-03-27 |
2012-03-13 |
Kyowa Hakko Kirin Co., Ltd. |
Compound inhibiting in vivo phosphorous transport and medicine containing the same
|
US20050244367A1
(en)
|
2004-05-03 |
2005-11-03 |
Ilypsa, Inc. |
Phospholipase inhibitors localized in the gastrointestinal lumen
|
MXPA06013236A
(es)
|
2004-05-14 |
2007-02-28 |
Univ North Carolina |
Prouroguanilina, y analogos sinteticos o productos de escision proteolitica derivados de la misma, como agentes terapeuticos y de diagnostico para enfermedades que comprenden hemeostasis de sales y/o fluidos.
|
DE102004046492A1
(de)
|
2004-09-23 |
2006-03-30 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
DE102004054847A1
(de)
|
2004-11-13 |
2006-05-24 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
DE102005001411A1
(de)
|
2005-01-12 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
DE102005044817A1
(de)
|
2005-09-20 |
2007-03-22 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
DE102005044815A1
(de)
|
2005-09-20 |
2007-03-22 |
Sanofi-Aventis Deutschland Gmbh |
Verwendung von Inhibitoren des Na+/H+ Austauschers, Subtyp 5 (NHE5) zur Gedächtnisverbesserung
|
MX2008005666A
(es)
|
2005-11-03 |
2009-03-02 |
Ilypsa Inc |
Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2.
|
EP1951315A2
(fr)
|
2005-11-03 |
2008-08-06 |
Ilypsa, Inc. |
Inhibiteurs de phospholipases, notamment inhibiteurs de phospholipases multivalents, leur utilisation, notamment en tant qu'inhibiteurs de phospholipases localises dans une lumiere
|
WO2008002971A2
(fr)
|
2006-06-29 |
2008-01-03 |
Microbia, Inc. |
Procédés et compositions destinés au traitement de troubles gastro-intestinaux
|
WO2008106429A2
(fr)
|
2007-02-26 |
2008-09-04 |
Ironwood Pharmaceuticals, Inc. |
Procédés et compositions pour le traitement de l'insuffisance cardiaque et d'autres troubles
|
MX2009011898A
(es)
|
2007-05-04 |
2009-11-18 |
Ironwood Pharmaceuticals Inc |
Composiciones y metodos para tratar trastornos asociados con retencion de sal o fluido.
|
MX2011001821A
(es)
|
2008-09-02 |
2011-03-25 |
Sanofi Aventis |
Aminoindanos sustituidos y sus analogos, y el uso farmaceutico de los mismos.
|
US10543207B2
(en)
|
2008-12-31 |
2020-01-28 |
Ardelyx, Inc. |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
MX345283B
(es)
|
2008-12-31 |
2017-01-24 |
Ardelyx Inc |
Compuestos y metodos para inhibir el antiporte mediado por intercambiador de iones de sodio/iones de hidrogeno (nhe) en el tratamiento de trastornos asociados con retencion de fluido o sobrecarga de sal y trastornos del tracto gastrointestinal.
|
EP2591354B1
(fr)
|
2010-07-07 |
2016-09-07 |
Ardelyx, Inc. |
Composés et procédés pour l'inhibition du transport de phosphate
|
WO2012006473A1
(fr)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Composés et procédés pour l'inhibition du transport de phosphate
|
WO2012006477A1
(fr)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Composés et procédés pour l'inhibition du transport de phosphate
|
WO2012054110A2
(fr)
|
2010-07-07 |
2012-04-26 |
Ardelyx, Inc. |
Composés et procédés permettant d'inhiber le transport du phosphate
|
EP2755974A1
(fr)
*
|
2011-09-14 |
2014-07-23 |
Proximagen Limited |
Nouveaux composés inhibiteurs enzymatiques
|
JP6726964B2
(ja)
*
|
2012-08-21 |
2020-07-22 |
アーデリクス,インコーポレーテッド |
体液貯留又は塩過負荷に関係する疾患及び消化管疾患の治療におけるnhe仲介の逆輸送を阻害するための化合物並びに方法
|
CA2880338A1
(fr)
|
2012-08-21 |
2014-02-27 |
Ardelyx, Inc. |
Composes et procedes d'inhibition d'un antiport a mediation par nhe dans le traitement de troubles associes a une retention de fluide ou a une surcharge de sel et de troubles du tractus gastro-intestinal
|
KR20230132619A
(ko)
|
2013-04-12 |
2023-09-15 |
알데릭스, 인코포레이티드 |
Nhe3-결합 화합물 및 포스페이트 수송을 저해하는 방법
|
US9932331B2
(en)
*
|
2014-07-25 |
2018-04-03 |
Taisho Pharmaceutical Co., Ltd. |
Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
|
JP7292207B2
(ja)
*
|
2017-01-09 |
2023-06-16 |
アルデリックス, インコーポレイテッド |
消化管障害を処置するために有用な化合物
|